watch her tomorrow punters, page-4

Hi T we appreciate more views in BPO, I consider BPOs R&D/pre-commercialisation profile and illiquid trading patterns a big factor to rely solely on TA, especially after the latest Cap raising. [I acknowledge it was limited by holder ratios but it was underwritten by financier - they have done well and I believe brought in new participative bakers off the unsubscribed pool distributions at the same time].

Mind you a bit of old school FA with consolidative or progressive news will most probably get those figures - so TA vs. FA driver would be moot at that point. The
ability to use the Agvet Coded active constituent CGNC and having access to alternate suppliers is IMO an early milestone enabler ? a big plus to commercialisation target.

Two views similar SP outlook, the market will determine our confidence.